| Literature DB >> 35681892 |
Andrzej Gawor1, Anna Ruszczyńska1, Anna Konopka1, Grzegorz Wryk1, Marian Czauderna2, Ewa Bulska1.
Abstract
Selenium is an essential nutrient, building twenty five identified selenoproteins in humans known to perform several important biological functions. The small amount of selenium in the earth's crust in certain regions along with the risk of deficiency in organisms have resulted in increasingly popular dietary supplementation in animals, implemented via, e.g., inorganic selenium compounds. Even though selenium is included in selenoproteins in the form of selenocysteine, the dietary effect of selenium may result in the expression of other proteins or genes. Very little is known about the expression effects modulated by selenium. The present study aimed to examine the significance of protein expression in lamb tissues obtained after dietary supplementation with selenium (sodium selenate) and two other feed additives, fish oil and carnosic acid. Label-free mass spectrometry-based proteomic analysis was successfully applied to examine the animal tissues. Protein-protein interaction network analysis of forty differently-expressed proteins following inorganic selenium supplementation indicated two significant clusters which are involved in cell adhesion, heart development, actin filament-based movement, plasma membrane repair, and establishment of organelle localization.Entities:
Keywords: label-free mass spectrometry; protein-protein interaction; proteomics; selenium; supplementation
Year: 2022 PMID: 35681892 PMCID: PMC9179315 DOI: 10.3390/ani12111428
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1Overview of proteomics analysis: (a) the overlap between all identified proteins in Group 0 and Group SeVI, shown as a Venn diagram; (b) The number of up- and downregulated proteins obtained by comparing Group 0 and Group SeVI.
The list of up- (↑) and down- (↓) regulated proteins in Group 0 (2% RO, 1% FO and 0.1% CA) in comparison with Group SeVI (2% RO, 1% FO, 0.1% CA and 0.35 mg Se as Se(VI) in 1 kg BD); FDR = 1%; s0 = 1; adjusted p < 0.01.
| Difference | Protein IDs | Protein Names | -Log | Seq. Coverage [%] | Mol. Weight |
|---|---|---|---|---|---|
| ↑+2.43 | W5PTT8 | Four and a half LIM domains 2 | 1.86 | 45 | 32.859 |
| ↑+2.11 | W5Q7R8 | Junction plakoglobin | 3.80 | 27 | 81.961 |
| ↑+1.76 | W5QFG6 | Actin related protein 2 | 4.16 | 19 | 52.197 |
| ↑+1.71 | W5NTG3 | Glycine cleavage system H protein | 2.81 | 27 | 19.109 |
| ↑+1.70 | W5NSS8 | Tubulin beta chain | 3.69 | 61 | 47.985 |
| ↑+1.69 | W5QBQ9 | Myosin heavy chain 9 | 4.08 | 33 | 220.830 |
| ↑+1.68 | O78751 | ATP synthase protein 8 (A6L) | 1.71 | 55 | 7.910 |
| ↑+1.68 | W5P3Q8 | Catenin alpha 3 | 4.00 | 33 | 63.223 |
| ↑+1.65 | W5PK85 | EMAP like 2 | 3.98 | 17 | 68.515 |
| ↑+1.56 | W5Q731 | 59 kDa serine/threonine-protein kinase | 5.13 | 30 | 51.421 |
| ↑+1.56 | O78748 | NADH-ubiquinone oxidoreductase chain 2 | 2.52 | 15 | 39.128 |
| ↑+1.53 | W5P0Y1 | Ryanodine receptor 2 | 4.35 | 27 | 544.710 |
| ↑+1.50 | W5Q7Z7 | Desmoplakin | 2.83 | 35 | 317.880 |
| ↑+1.48 | A8D8X1 | 60S ribosomal protein L10 (Protein QM homolog) | 2.15 | 31 | 24.603 |
| ↑+1.47 | W5NY53 | Mannose-6-phosphate isomerase (EC 5.3.1.8) | 2.68 | 34 | 55.469 |
| ↑+1.46 | W5PSC5 | Myosin IC | 3.64 | 25 | 121.400 |
| ↑+1.45 | W5PW95 | Tubulin alpha chain | 3.85 | 39 | 54.886 |
| ↑+1.45 | W5QHK3 | Methylcrotonoyl-CoA carboxylase 1 | 3.79 | 29 | 77.352 |
| ↑+1.44 | W5PQG5 | Adenylyl cyclase-associated protein | 2.98 | 38 | 53.957 |
| ↑+1.44 | W5P9K6 | Proteasome 26S subunit, ATPase 3 | 2.12 | 29 | 50.645 |
| ↑+1.37 | W5PPG2 | Dysferlin | 2.41 | 24 | 234.250 |
| ↑+1.30 | W5Q5C7 | Catenin alpha 1 | 2.45 | 27 | 100.090 |
| ↑+1.30 | W5NZ80 | Niban apoptosis regulator 1 | 2.63 | 17 | 103.360 |
| ↑+1.27 | W5Q7M7 | Heterogeneous nuclear ribonucleoprotein A3 | 3.91 | 37 | 39.709 |
| ↑+1.26 | W5NU63 | Myosin heavy chain 10 | 3.24 | 27 | 229.100 |
| ↑+1.25 | W5QCD6 | Isocitrate dehydrogenase [NADP] (EC 1.1.1.42) | 2.95 | 32 | 46.733 |
| ↑+1.25 | W5NY24 | Catenin beta 1 | 5.08 | 33 | 85.609 |
| ↑+1.23 | W5P5A0 | Filamin A | 4.26 | 24 | 279.600 |
| ↑+1.21 | W5QGW8 | Phosphodiesterase (EC 3.1.4.) | 2.98 | 22 | 92.055 |
| ↑+1.15 | W5PUT6 | Clathrin heavy chain | 3.84 | 32 | 191.880 |
| ↓−1.32 | W5NPQ4 | F-actin-capping protein subunit alpha | 9.33 | 64 | 36.331 |
| ↓−1.38 | W5Q8I4 | ST13 Hsp70 interacting protein | 2.05 | 20 | 43.341 |
| ↓−1.51 | W5PQ67 | Myosin light chain 4 | 1.55 | 72 | 21.296 |
| ↓−1.51 | W5PZY7 | Ubiquitin carboxyl extension protein 80 | 1.99 | 39 | 19.543 |
| ↓−1.52 | W5P7E8 | Dual specificity protein phosphatase | 3.12 | 24 | 18.843 |
| ↓−1.54 | W5PQK7 | Eukaryotic translation initiation factor 5A | 1.72 | 43 | 17.171 |
| ↓−1.88 | W5Q4D9 | NAD(P)(+)--arginine ADP-ribosyltransferase | 2.56 | 19 | 43.748 |
| ↓−1.89 | W5Q5Z9 | MICOS complex subunit | 3.11 | 18 | 23.119 |
| ↓−1.92 | W5NUL7 | AFG3 like matrix AAA peptidase subunit 2 | 2.95 | 20 | 89.411 |
| ↓−2.28 | W5Q2R9 | UBC core domain-containing protein | 4.68 | 61 | 17.394 |
Figure 2Gene ontology enrichment analysis of the identified differentially-expressed proteins in three categories: (a) biological process; (b) molecular function; and (c) cellular components. The abscissa was the –log (q-value) in order to show the significance between the proteins involved in feature function and annotation; this parameter describes the significance of the enrichment. The displayed q-values are corrected FDR values for multiple testing within each category, for which the Benjamini–Hochberg procedure was used.
Figure 3Protein-protein interaction network of differentially regulated proteins after inorganic selenium supplementation with the addition of 2% RO, 1% FO, 0.1% CA: (a) legend; (b) protein–protein interaction network analysis for all differentially expressed proteins; (c,d) two interactions between protein complexes from the STRING database formed by means of the Markov Cluster Algorithm. The number of lines represents the strength of predicted functional interactions between proteins.